Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul Rivard Insider Profile
11 Followers
Paul Rivard, CLO at TNF Pharmaceuticals, holds 400.00K shares in TNF Pharmaceuticals (Ticker: TNFA). Most recently, Paul Rivard Bought $150,000 shares of TNF Pharmaceuticals on Aug 24, 2023 for an estimated value of 166.50K.
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-85.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
CLO
Roles that Paul Rivard holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 24, 2021 - Nov 24, 2022
Return:-69.40%
The most profitable trade made by Paul Rivard
Paul Rivard's Trading History
List of latest transactions for each holding click on a transaction to see Paul Rivard's performance on stock
You May Also Like
Paul Rivard insider profile FAQ
What is the percentage of profitable transactions made by Paul Rivard?
The percentage of profitable transactions made by Paul Rivard is 0%.
What is the average return per transaction made by Paul Rivard?
The average return per transaction made by Paul Rivard is -85.40%.
What stocks does Paul Rivard hold?
Paul Rivard holds: TNFA stocks.
What was Paul Rivard’s latest transaction?
Paul Rivard latest transaction was an Informative Buy of $166.50K.
What was Paul Rivard's most profitable transaction?
Paul Rivard’s most profitable transaction was an Informative Buy of TNFA stock on November 24, 2021. The return on the trade was -69.40%.
What is Paul Rivard's role in TNF Pharmaceuticals?
Paul Rivard's role in TNF Pharmaceuticals is CLO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.